{"id":948013,"date":"2026-03-31T11:23:25","date_gmt":"2026-03-31T15:23:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/"},"modified":"2026-03-31T11:23:25","modified_gmt":"2026-03-31T15:23:25","slug":"recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/","title":{"rendered":"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK and SALT LAKE CITY, March  31, 2026  (GLOBE NEWSWIRE) &#8212; Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology through advanced data science and automation.<\/p>\n<p>Recursion\u2019s end-to-end platform is designed to connect discovery through development by integrating proprietary multimodal datasets, purpose-built AI models, and experimental biology. The addition of Citeline\u2019s real-world data and evidence capabilities strengthens this foundation, enabling more precise trial design, improved site selection, and faster, more informed development decisions.<\/p>\n<p>\u201cRecursion has been an exceptional partner to Norstella [Citeline\u2019s parent company] and Citeline, consistently pushing the boundaries of what\u2019s possible at the intersection of biology, technology, and data,\u201d said Fred Hassan, Norstella Executive Chair. \u201cWe\u2019re proud of the impact our real-world data have already had across their programs, and integrating Citeline SmartSolutions into their platform will help ensure their teams have the clarity and foresight they need from the earliest stages of development.\u201d<\/p>\n<p>\u201cThe addition of Citeline\u2019s data and evidence capabilities to Recursion\u2019s robust platform has meaningfully supported our pipeline, including contextualization of single-arm data from our REC-4881 Phase I\/II study,\u201d said Najat Khan, CEO and President of Recursion. \u201cInvestment in our ClinTech platform is already yielding results, including 30\u201360% improvements in enrollment, demonstrating the power of this integrated approach.\u201d<\/p>\n<p>This expanded collaboration reflects a shared commitment to building a more predictive, connected, and patient-centered biopharmaceutical ecosystem \u2014 where insights from real-world data inform decisions from the earliest stages of discovery through clinical development, ultimately accelerating the path from pipeline to patient.<\/p>\n<p>For more information, visit Citeline.com.<\/p>\n<p>\n        <strong>About Citeline<\/strong><br \/>\n        <br \/>Citeline, a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tNYFh05FXTIEp4601loby1AMJ32go_dwNRDb8AIg1zhUY0JFANfg14VZ0KNTattjLea2cZz21JU2kFhV-SKHsw==\" rel=\"nofollow\" target=\"_blank\">Norstella<\/a> company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.\u00a0<\/p>\n<p>Citeline\u2019s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical, and medtech industries, covering them all with expert insights: key diseases, clinical trials, drug R&amp;D and approvals, market forecasts, and more. For more information on one of the world\u2019s most trusted health science partners, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hmFE0-PPNE8NtxZ-9jqsvKrbGnLzJPJxfrGIHK1Y8rwTfM1OX1lP91lr0QUD1exqgQ4Ljmup5cUGpVZTHCNDrg==\" rel=\"nofollow\" target=\"_blank\"><u>Citeline<\/u><\/a> and follow on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4wA-BdokDwazqtemMPY1cJOScmlPR-SQ9uCnt-3xg1AYe5wSeDOad0cQfQVLhw-yaps1Essy1asWqWoo-r1gpX-e52Y-eshvXnT7GxJvaeY=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mJS7-wrPctF7g8PhbD2SQnBowoL0MjBteqZs1BMpQn3C966I2QpD7kdpcQIuVcCk3dwOO7y3H1VqPaEI2VsvWg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>About Recursion<\/strong><br \/>\n        <br \/>Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need.<\/p>\n<p>Enabling its mission is Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, Recursion OS is designed to translate complex science into medicines that matter \u2014 faster, better, and at scale \u2014 for patients who are waiting. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L1BY4mDERv5HF9Qd4GIk2Iq9-U7hPqYVsqixQr2sYWTUYp8Am6SyYJHD50Ctv7Q0oDEtNHx64m7czplJWb8s3h6gZfNzm9vo1-q-eS2fCyU=\" rel=\"nofollow\" target=\"_blank\">www.recursion.com<\/a>, or connect on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lairge0-QIPZXt4MarUpBaZ34SC__jHzKkxV20nuSU20LgeC3nBgvlnpHaCeEwsrJtJ6lORskobTbpn5ruOerg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4wA-BdokDwazqtemMPY1cPmWWvKfa2lBXQwGB-29XKd5w6pMoisOpit3bfuWcLQnPZVbB8vWmSxiWezpCK6fNvvHyDrhDQOQjDana13Qv8l3xoCMhDgXL6H8av1mz1Jl\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>Citeline PR contact:<br \/>Diffusion PR for Citeline<br \/>Norstella@DiffusionPR.com<br \/>(213) 318-4500<\/p>\n<p>Recursion Media Contact<br \/>media@recursion.com<\/p>\n<p>Recursion Investor Contact<br \/>investor@recursion.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmY1OTQ1NzMtZDRkZi00NzMyLWExYWUtYzEzM2MwZDFmMzgyLTEwNDA3ODMtMjAyNi0wMy0zMS1lbg==\/tiny\/Caerus-Us-1-Inc-dba-Citeline-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) &#8212; Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology through advanced data science and automation. Recursion\u2019s end-to-end platform is designed to connect discovery through development by integrating proprietary multimodal datasets, purpose-built AI models, and experimental biology. The addition of Citeline\u2019s real-world data and evidence capabilities strengthens this foundation, enabling more precise trial design, improved site selection, and faster, more informed development decisions. \u201cRecursion has been an exceptional partner to Norstella [Citeline\u2019s parent company] and Citeline, consistently pushing the boundaries of what\u2019s possible at the intersection of biology, technology, and data,\u201d &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-948013","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) &#8212; Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology through advanced data science and automation. Recursion\u2019s end-to-end platform is designed to connect discovery through development by integrating proprietary multimodal datasets, purpose-built AI models, and experimental biology. The addition of Citeline\u2019s real-world data and evidence capabilities strengthens this foundation, enabling more precise trial design, improved site selection, and faster, more informed development decisions. \u201cRecursion has been an exceptional partner to Norstella [Citeline\u2019s parent company] and Citeline, consistently pushing the boundaries of what\u2019s possible at the intersection of biology, technology, and data,\u201d &hellip; Continue reading &quot;Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-31T15:23:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform\",\"datePublished\":\"2026-03-31T15:23:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/\"},\"wordCount\":551,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/\",\"name\":\"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=\",\"datePublished\":\"2026-03-31T15:23:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/","og_locale":"en_US","og_type":"article","og_title":"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - Market Newsdesk","og_description":"NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) &#8212; Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology through advanced data science and automation. Recursion\u2019s end-to-end platform is designed to connect discovery through development by integrating proprietary multimodal datasets, purpose-built AI models, and experimental biology. The addition of Citeline\u2019s real-world data and evidence capabilities strengthens this foundation, enabling more precise trial design, improved site selection, and faster, more informed development decisions. \u201cRecursion has been an exceptional partner to Norstella [Citeline\u2019s parent company] and Citeline, consistently pushing the boundaries of what\u2019s possible at the intersection of biology, technology, and data,\u201d &hellip; Continue reading \"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-31T15:23:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform","datePublished":"2026-03-31T15:23:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/"},"wordCount":551,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/","name":"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=","datePublished":"2026-03-31T15:23:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc1MCM3NTEwMDkzIzIwMjkyMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-expands-strategic-partnership-with-citeline-to-advance-its-ai-enabled-clintech-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/948013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=948013"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/948013\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=948013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=948013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=948013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}